Mannatech Reports Financial Results for Third Quarter 2026

FLOWER MOUND, Texas – Mannatech, Incorporated (NASDAQ: MTEX), (“Mannatech” or “Company”), global health and wellness company committed to transforming lives to make a better world, announced financial results for its third quarter of 2026.

Third Quarter Results

• Net sales for the three months ended September 30, 2026 were $24.9 million, a decrease of $4.3 million, as compared to the same period in 2025. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $4.3 million, or 14.6%, and foreign exchange had no effect on GAAP net sales as compared to the same period in 2025.

• Gross profit as a percentage of net sales decreased to 74.7% for the three months ended September 30, 2026, as compared to 76.4% for the same period in 2025.

• For the three months ended September 30, 2026, selling and administrative expenses decreased by $0.4 million, or 4.1%, to $8.7 million, as compared to the same period in 2025. Selling and administrative expenses, as a percentage of net sales, for the three months ended September 30, 2026 increased to 35.0% from 31.1% for the same period in 2025.

• Income from operations was $0.3 million for the three months ended September 30, 2026, as compared to income from operations of $2.0 million in the same period in 2025.

• Income tax benefit was $10.9 million for the three months ended September 30, 2026, as compared to income tax expense of $0.6 million for the same period in 2025, resulting from a non-cash remeasurement of deferred tax liabilities on unremitted foreign earnings. This benefit did not generate cash.

• Net income was $8.9 million for the three months ended September 30, 2026, or $4.61 per diluted share, as compared to net income of $1.9 million, or $1.01 per diluted share for the three months ended September 30, 2025. The Company reported a pre-tax loss of approximately $2.0 million for the three months ended September 30, 2026, as compared to pre-tax income of $2.5 million for the same period in 2025. Third quarter net income was driven primarily by a $10.9 million non-cash income tax benefit and does not reflect an improvement in operating performance.

• Net realized and unrealized foreign currency loss for the three months ended September 30, 2026 was $2.1 million, as compared to net realized and unrealized foreign currency gains of $0.6 million for the three months ended September 30, 2025.

• As of September 30, 2026, the Company’s cash and cash equivalents decreased 12.4%, or $0.8 million, to $5.4 million from $6.2 million as of December 31, 2025.

Management’s Statement

Changes in current trade policies, including with respect to tariffs, could affect our cost structure and profitability. While we take steps to mitigate or avoid these increased costs and disruptions, our ability to do so may be limited by operational and supply chain constraints and uncertainties, especially in the short term.

Non-GAAP Financial Measures

In addition to results presented in accordance with GAAP, this press release and related tables include certain non-GAAP financial measures, including a presentation of Constant dollar measures. The company discloses operating results that have been adjusted to exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, including changes in: Net Sales, Gross Profit, and Loss from Operations.

The Company believes that these non-GAAP financial measures provide useful information to investors because they are an indicator of the strength and performance of ongoing business operations. The constant currency figures are financial measures used by management to provide investors with an additional perspective on trends. Although management believes the non-GAAP financial measures enhance investors’ understanding of their business and performance, these non-GAAP financial measures should not be considered an exclusive alternative to accompanying GAAP financial measures. Please see the accompanying table entitled “Non-GAAP Financial Measures” for a reconciliation of these non-GAAP financial measures.

Click here to view the full Mannatech Q3 Report

About Mannatech

Mannatech is a leading global health and wellness company committed to empowering everyone to live their best life through cutting-edge, science-backed nutritional products, patented technology, and a rewarding business opportunity. Mannatech helps people to live healthier, more fulfilling lives while making a positive social impact in the world. To learn more about Mannatech’s products or business opportunity, visit Mannatech.com.

SOURCE: Mannatech